Rationally designed molecular beacons for bioanalytical and biomedical applications

Abstract

Nucleic acids hold promise as biomolecules for future applications in biomedicine and biotechnology. Their well-defined structures and compositions afford unique chemical properties and biological functions. Moreover, the specificity of hydrogen-bonded Watson-Crick interactions allows the construction of nucleic acid sequences with multiple functions. In particular, the development of nucleic acid probes as essential molecular engineering tools will make a significant contribution to advancements in biosensing, bioimaging and therapy. The molecular beacon (MB), first conceptualized by Tyagi and Kramer in 1996, is an excellent example of a double-stranded nucleic acid (dsDNA) probe. Although inactive in the absence of target, dsDNA probes can report the presence of a specific target through hybridization or specific recognition-triggered change in conformation. MB probes are typically fluorescently labeled oligonucleotides that range from 25 to 35 nucleotides (nt) in length, and their structure can be divided into three components: stem, loop and reporter. The intrinsic merit of MBs depends on predictable design, reproducibility of synthesis, simplicity of modification, and built-in signal transduction. Using resonance energy transfer (RET) for signal transduction, MBs are further endowed with increased sensitivity, rapid response and universality, making them ideal for chemical sensing, environmental monitoring and biological imaging, in contrast to other nucleic acid probes. Furthermore, integrating MBs with targeting ligands or molecular drugs can substantially support their in vivo applications in theranositics. In this review, we survey advances in bioanalytical and biomedical applications of rationally designed MBs, as they have evolved through the collaborative efforts of many researchers. We first discuss improvements to the three components of MBs: stem, loop and reporter. The current applications of MBs in biosensing, bioimaging and therapy will then be described. In particular, we emphasize recent progress in constructing MB-based biosensors in homogeneous solution or on solid surfaces. We expect that such rationally designed and functionalized MBs will open up new and exciting avenues for biological and medical research and applications.

Cy5/BHQ dye–quencher pairs in fluorogenic qPCR probes: effects of charge and hydrophobicity

“…21 Anyway one should take in mind that dye-dye and dye-nucleic acids interactions influence on thermal stability of convoluted probes. We demonstrated here that thermal quenching is less pronounced for Cy5 than for sCy5.…”

Nucleic acid-functionalized transition metal nanosheets for biosensing applications

“…Aptamers are selected by a technique known as “systematic evolution of ligands by exponential enrichment” (SELEX), and they exhibit high affinity towards a wide range of targets, such as small organic molecules, metal ions, proteins and cells (Ellington and Szostak 1990; Fang and Tan 2010; Tuerk and Gold 1990). Therefore, the introduction of aptamers can significantly expand the application scope of nucleic acid-based biosensors (Chen et al 2011; Chen et al 2015a; Shukoor et al 2012; Tan et al 2013; Yasun et al 2012; Zheng et al 2015). Metallo-base pairs also provide a feasible recognition strategy for biosensing.…”

From Interface to Solution: Integrating Immunoassay with Netlike Rolling Circle Amplification for Ultrasensitive Detection of Tumor Biomarker

“…A variety of biosensing strategies 13, amplification strategies 14, nanomaterials 15 and molecular labels 16 are involved. However, in most cases, the reactions in solution still partially rely on interface (either solid surface or nanomaterials surface) 17-18.…”